Byrne Asset Management’s CervoMed CRVO Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVO
Byrne Asset Management's CRVO Position: Q2 2026 in Review
Byrne Asset Management increased its CervoMed (CRVO) stake by 249% in Q2 2026, buying an estimated $129K and bringing the position to 51,250 shares worth $159K. The position accounts for 0.09% of the portfolio, ranked #179.
Byrne Asset Management first reported a position in CRVO in Q4 2025 and has held it in 3 quarters since. 2 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.
- Byrne Asset Management held 51,250 shares of CervoMed worth $159K as of Q2 2026.
- Byrne Asset Management bought 36,550 CervoMed shares in Q2 2026, an estimated $129K.
- CervoMed made up 0.09% of Byrne Asset Management's portfolio in Q2 2026, its #179 holding.
- Byrne Asset Management first reported a position in CervoMed in Q4 2025 and has held it in 3 quarters since.
- 2 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.
Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.